Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/07/2010 | US20100003365 Cloning, expression and use of acid phospholipases |
01/07/2010 | US20100003299 RNAi Methods and Compositions for Stimulating Proliferation of Cells with Adherent Functions |
01/07/2010 | US20100003286 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
01/07/2010 | US20100003280 Adjuvant compositions |
01/07/2010 | US20100003277 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
01/07/2010 | US20100003269 Methods and uses of cauliflower and collard for recombinant protein production |
01/07/2010 | US20100003266 Targeted immune conjugates |
01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
01/07/2010 | US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
01/07/2010 | US20100003242 antibody that binds sphingosine-1-phosphate (S1P); used for detection of S1P or for treatment of diseases and conditions associated with S1P |
01/07/2010 | US20100003241 Agents for treatment or prevention of an allergic disorder |
01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
01/07/2010 | US20100003232 Insulin-degrading enzyme mutants and methods of use |
01/07/2010 | US20100003229 Nuclear telomerase reverse transcriptase variant |
01/07/2010 | US20100003218 Hybrid-aav vectors to deliver large gene expression cassette |
01/07/2010 | DE102008031666A1 Kryobehälter Cryocontainers |
01/07/2010 | DE102008031350A1 Prokaryotische Xylose-Isomerase zur Konstruktion Xylose-vergärender Hefen Prokaryotic xylose isomerase xylose fermenting yeasts for construction |
01/07/2010 | DE102008030435A1 Neuartige Varianten PQQ-abhängiger Glukosehydrogenase mit verbesserter Substratspezifität Novel variants PQQ-dependent Glukosehydrogenase with improved substrate specificity |
01/07/2010 | CA2731981A1 Antibody complex, method for detecting antigen, and method for producing antibody complex |
01/07/2010 | CA2729897A1 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtgpat1) |
01/07/2010 | CA2729839A1 High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein |
01/07/2010 | CA2729821A1 Genetic markers associated with degenerative disc disease and uses thereof |
01/07/2010 | CA2729818A1 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides |
01/07/2010 | CA2729810A1 Tgf-.beta. antagonist multi-target binding proteins |
01/07/2010 | CA2729801A1 Compositions and methods for producing isoprene free of c5 hydrocarbons under decoupling conditions and/or safe operating ranges |
01/07/2010 | CA2729793A1 Msp-1 protein preparations from plasmodium |
01/07/2010 | CA2729749A1 Tnf-a antagonist multi-target binding proteins |
01/07/2010 | CA2729713A1 Recombinant dna constructs and methods for modulating expression of a target gene |
01/07/2010 | CA2729628A1 Industrial plant-based production of animal-free recombinant proteins in defined environment |
01/07/2010 | CA2729625A1 Gene of porcine alpha-s1-casein, a promoter of the same and the use thereof |
01/07/2010 | CA2729623A1 A gene of porcine beta-casein, a promoter of the same and the use thereof |
01/07/2010 | CA2729567A1 Anti-cd27 antibody |
01/07/2010 | CA2729496A1 Promoters from brassica napus for seed specific gene expression |
01/07/2010 | CA2729403A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
01/07/2010 | CA2729187A1 Production of alkenes by enzymatic decarboxylation of 3-hydroxyalkanoic acids |
01/07/2010 | CA2729080A1 Cattle vaccines |
01/07/2010 | CA2728926A1 Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a tfl1-like protein |
01/07/2010 | CA2728762A1 Rna antagonists targeting hsp27 |
01/07/2010 | CA2728682A1 Prokaryotic xylose isomerase for the construction of xylose fermenting yeasts |
01/07/2010 | CA2728622A1 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
01/07/2010 | CA2728291A1 Minicircle dna vector preparations and methods of making and using the same |
01/07/2010 | CA2726297A1 Synthetic pathway enzymes for the production of argyrins |
01/06/2010 | EP2141244A1 Multiplex quantification of nucleic acids in diseased cells |
01/06/2010 | EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins |
01/06/2010 | EP2141242A1 Synthetic pathway enzymes for the production of Argyrins |
01/06/2010 | EP2141241A1 Senescence cells and methods for its production |
01/06/2010 | EP2141240A2 Plants that can tolerate herbicides by bypassing the metabolic route |
01/06/2010 | EP2141239A1 Dominant gene suppression transgenes and methods of using same |
01/06/2010 | EP2141238A1 DNA cloning vector plasmids and methods for their use |
01/06/2010 | EP2141237A1 Method for reducing the fucose content of recombinant proteins |
01/06/2010 | EP2141236A1 Process for production of lipstatin and microorganisms therefore |
01/06/2010 | EP2141235A1 Adiponectin receptor and gene coding for the same |
01/06/2010 | EP2141234A1 Short Interfering RNA (siRNA) Analogues |
01/06/2010 | EP2141233A1 Antisense design |
01/06/2010 | EP2141232A1 Polyamino acid synthetase and gene encoding the same |
01/06/2010 | EP2141231A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR |
01/06/2010 | EP2141228A1 Method for the generation of proliferating and differentiating B cell lines |
01/06/2010 | EP2141227A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
01/06/2010 | EP2141179A1 A fluorescence based reporter construct for the direct detection of TGF-beta receptor activation and modulators thereof |
01/06/2010 | EP2141177A1 MSP-1 protein preparations from Plasmodium |
01/06/2010 | EP2141175A1 Process for synthesizing cyclic peptide compound |
01/06/2010 | EP2141173A1 Methods and compositions for the inhibition of gene expression |
01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
01/06/2010 | EP2140877A1 New use of coccidian |
01/06/2010 | EP2140876A1 Therapeutic agent comprising vasohibin |
01/06/2010 | EP2140247A1 Method for modulating activity of t lymphocytes |
01/06/2010 | EP2140034A1 Selection method for cell internalizing nucleic acids |
01/06/2010 | EP2140015A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
01/06/2010 | EP2140014A1 Mutagenized tobacco plant as seed culture for the production of oil for energetic, industrial and alimentary uses |
01/06/2010 | EP2140013A2 Herbicide-resistant brassica plants and methods of use |
01/06/2010 | EP2140012A2 Plants having increased tolerance to heat stress |
01/06/2010 | EP2140010A2 Methods and compositions for selecting soybean plants resistant to phytophthora root rot |
01/06/2010 | EP2140009A2 Transgenic plants containing soluble cell wall polysaccharides |
01/06/2010 | EP2140008A2 Yeast expression systems |
01/06/2010 | EP2140007A1 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
01/06/2010 | EP2140006A1 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
01/06/2010 | EP2140005A1 Antagonists of ligands and uses thereof |
01/06/2010 | EP2140004A2 Genetic suppression and replacement |
01/06/2010 | EP2140003A2 Sample-processing reagent compositions, methods, and devices |
01/06/2010 | EP2140002A1 Compositions, methods, and devices for isolating biological materials |
01/06/2010 | EP2140001A2 Methods for nucleic acid amplification |
01/06/2010 | EP2140000A1 Method of enhancing migration of neural precursor cells |
01/06/2010 | EP2139998A1 Vector with codon-optimised genes for an arabinose metabolic pathway for arabinose conversion in yeast for ethanol production |
01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
01/06/2010 | EP2139992A1 A method of modulating the activity of a nucleic acid molecule |
01/06/2010 | EP2139991A1 Targeted neuronal and glial human embryonic stem cell line |
01/06/2010 | EP2139917A2 Anti-androgen peptides and uses thereof in cancer therapy |
01/06/2010 | EP2139913A2 Inducing immune-mediated tumor cell death |
01/06/2010 | EP2139909A1 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
01/06/2010 | EP2139908A2 Li-rnai involved li suppression in cancer immunotherapy |
01/06/2010 | EP2139319A2 Methods and compositions related to riboswitches that control alternative splicing |
01/06/2010 | EP1902142B1 3'modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
01/06/2010 | EP1476573B1 Crude biological derivatives competent for nucleic acid detection |
01/06/2010 | EP1476562B1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |